AB0439 ADALIMUMAB AND NUMBER OF PREVIOUS BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS AS PREDICTIVE FACTORS FOR THE DEVELOPMENT OF IMMUNE-MEDIATED SKIN LESIONS

Martins, A ; D Santos Oliveira ; Martins, F R ; Nicolau, R ; F Oliveira Pinheiro ; Rato, M ; Bernardo, A ; Pimenta, S ; Bernardes, M ; Costa, L

Annals of the rheumatic diseases, 2023, Vol.82 (Suppl 1), p.1408-1408 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível